4.5 Article

Microfluidic process intensification for synthesis and formulation in the pharmaceutical industry

出版社

ELSEVIER SCIENCE SA
DOI: 10.1016/j.cep.2019.107559

关键词

Microfluidics; Pharmaceuticals; Lab-on-a-chip; Drug delivery; Microreactors; Synthesis

资金

  1. Australian Academy of Science, on behalf of the Department of Industry, Innovation and Science
  2. Australian Government under the National Innovation and Science Agenda

向作者/读者索取更多资源

Process intensification has had an enormous impact on industrial strategy over the last century, with good outcomes for efficiency, safety, environment, and financial cost. Microfluidics offers a relatively new approach that has been studied for 30 years and has become a realistic tool for process intensification in important areas, including pharmaceutical industry. Drug manufacturing and development are expensive, highly regulated, and of great importance to society, due to the health care application. It is therefore a natural target for new technologies that can make pharmaceuticals simultaneously cheaper, more effective, and more accessible, without adverse impact on the environment and health of the workforce. Much work has been done, so this review will necessarily focus on improved pharmaceutical synthesis and drug delivery systems. This review also highlights examples of process intensification and future directions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据